|
|
|
|
|
by throwawaygh
2138 days ago
|
|
> what’s the end game for the cellular signaling modeling outlined in the article? Pharma. Most of the modeling work that people do is fairly well motivated. Going from models to working technology is indeed a huge leap, but everything starts with the basic scientific understanding. > Maybe I’m wrong and there are people working on the big picture. You can usually find the "big picture" behind a paper by reading the recent grant applications from the PI who funded the research (or the funding lines explicitly mentioned in the paper, if any). |
|
No competent physician would be satisfied with a disembodied diagnosis. The constituent symptoms and assay metrics that support that diagnosis are essential to know, especially as disease is often complex and dynamic, and no single diagnostic label should ever hope to supplant a deeper understanding of each patient's unique mix of normality and abnormality. A diagnosis using ML may be a useful starting point in treatment, but never should be the endpoint.